Plus Therapeutics, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
PSTV Nasdaq 3840 plustherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Plus Therapeutics, Inc.

Plus Therapeutics Announces FDA Agreement to Initiate ReSPECT-LM Dose Optimization Trial for REYOBIQ™ in Leptomeningeal Metastases - Jun 30th, 2025 5:30 am
Plus Therapeutics Provides Business Update on CNSide Diagnostics Subsidiary - Jun 26th, 2025 5:30 am
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET - Jun 25th, 2025 2:15 pm
Sector Update: Health Care Stocks Advance Late Afternoon - Jun 25th, 2025 2:04 pm
Top Midday Gainers - Jun 25th, 2025 12:23 pm
Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer - Jun 25th, 2025 5:30 am
Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing - Jun 24th, 2025 5:30 am
Plus (PSTV) Upgraded to Buy: Here's Why - Jun 19th, 2025 10:00 am
Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates - May 30th, 2025 3:25 pm
Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates - May 30th, 2025 3:20 pm
Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights - May 30th, 2025 2:15 pm
The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates - May 29th, 2025 3:30 pm
Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q - May 23rd, 2025 2:15 pm
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Misses Revenue Estimates - May 15th, 2025 3:40 pm
Plus Therapeutics (PSTV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - May 14th, 2025 8:00 am
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates - May 14th, 2025 6:15 am
Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM) - May 14th, 2025 5:30 am
Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Misses Revenue Estimates - May 12th, 2025 3:10 pm
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates - May 8th, 2025 6:00 am
Plus Therapeutics to Participate in the D. Boral Capital Inaugural Global Conference - May 8th, 2025 5:00 am